PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $144,000 | -5.3% | 49,843 | 0.0% | 0.02% | -17.4% |
| Q4 2021 | $152,000 | -56.4% | 49,843 | 0.0% | 0.02% | -8.0% |
| Q3 2021 | $349,000 | -30.8% | 49,843 | -9.2% | 0.02% | -39.0% |
| Q2 2021 | $504,000 | -5.4% | 54,901 | 0.0% | 0.04% | +127.8% |
| Q1 2021 | $533,000 | -66.5% | 54,901 | -64.6% | 0.02% | -74.3% |
| Q4 2020 | $1,589,000 | +186.8% | 154,901 | +182.1% | 0.07% | +75.0% |
| Q3 2020 | $554,000 | -3.3% | 54,901 | 0.0% | 0.04% | -13.0% |
| Q2 2020 | $573,000 | +23.8% | 54,901 | 0.0% | 0.05% | +31.4% |
| Q1 2020 | $463,000 | -88.1% | 54,901 | -87.6% | 0.04% | -94.4% |
| Q4 2019 | $3,884,000 | – | 443,953 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |